Published in Pharm Res on March 01, 2000
Inhibition of brain tumor growth by intravenous poly (β-L-malic acid) nanobioconjugate with pH-dependent drug release [corrected]. Proc Natl Acad Sci U S A (2010) 2.05
Blood-brain barrier transport of therapeutics via receptor-mediation. Pharm Res (2007) 1.54
Noninvasive gene targeting to the brain. Proc Natl Acad Sci U S A (2000) 1.42
shRNA and siRNA delivery to the brain. Adv Drug Deliv Rev (2007) 1.42
Nanomedicine in the diagnosis and therapy of neurodegenerative disorders. Prog Polym Sci (2007) 1.41
Fusion antibody for Alzheimer's disease with bidirectional transport across the blood-brain barrier and abeta fibril disaggregation. Bioconjug Chem (2007) 1.36
Pharmacokinetics and safety in rhesus monkeys of a monoclonal antibody-GDNF fusion protein for targeted blood-brain barrier delivery. Pharm Res (2009) 1.32
CNS penetration of intrathecal-lumbar idursulfase in the monkey, dog and mouse: implications for neurological outcomes of lysosomal storage disorder. PLoS One (2012) 1.29
Brain-specific expression of an exogenous gene after i.v. administration. Proc Natl Acad Sci U S A (2001) 1.15
Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells. Fluids Barriers CNS (2013) 1.14
Neuroprotection in experimental stroke with targeted neurotrophins. NeuroRx (2005) 1.10
Targeting anti-HIV drugs to the CNS. Expert Opin Drug Deliv (2009) 1.05
Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery. Nanomedicine (Lond) (2008) 1.04
Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein. J Biotechnol (2010) 1.04
Localization of brain endothelial luminal and abluminal transporters with immunogold electron microscopy. NeuroRx (2005) 1.00
Antisense imaging of gene expression in the brain in vivo. Proc Natl Acad Sci U S A (2000) 0.93
Antibody-mediated targeting of siRNA via the human insulin receptor using avidin-biotin technology. Mol Pharm (2009) 0.92
Blood-brain barrier delivery of protein and non-viral gene therapeutics with molecular Trojan horses. J Control Release (2007) 0.90
A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier. PLoS One (2008) 0.89
Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy. NeuroRx (2005) 0.87
LRP-1-mediated intracellular antibody delivery to the Central Nervous System. Sci Rep (2015) 0.86
RNA interference and nonviral targeted gene therapy of experimental brain cancer. NeuroRx (2005) 0.84
IgG-single chain Fv fusion protein therapeutic for Alzheimer's disease: Expression in CHO cells and pharmacokinetics and brain delivery in the rhesus monkey. Biotechnol Bioeng (2010) 0.83
IgG-paraoxonase-1 fusion protein for targeted drug delivery across the human blood-brain barrier. Mol Pharm (2009) 0.81
Agile delivery of protein therapeutics to CNS. J Control Release (2014) 0.79
Targeting therapeutics across the blood brain barrier (BBB), prerequisite towards thrombolytic therapy for cerebrovascular disorders-an overview and advancements. AAPS PharmSciTech (2015) 0.75
Involvement of Insulin Signaling Disturbances in Bisphenol A-Induced Alzheimer's Disease-like Neurotoxicity. Sci Rep (2017) 0.75
A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell (1983) 18.86
Detection of specific hybridoma clones by replica immunoadsorption of their secreted antibodies. Proc Natl Acad Sci U S A (1979) 13.60
Natural history of acute coronary heart attacks. A community study. Br Heart J (1972) 8.55
Immunoglobulin gene expression in transformed lymphoid cells. Proc Natl Acad Sci U S A (1983) 5.18
Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med (2000) 4.99
Metabolic regulation of brain Abeta by neprilysin. Science (2001) 4.47
Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci U S A (1984) 3.32
Glass fiber contamination of cigarette filters: an additional health risk to the smoker? Cancer Epidemiol Biomarkers Prev (1998) 3.15
High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol (2001) 3.06
Urachal remnant diseases: spectrum of CT and US findings. Radiographics (2001) 2.82
Identification of CTX-M-14 extended-spectrum beta-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea. J Clin Microbiol (2001) 2.80
Structure of a cephalosporin synthase. Nature (1998) 2.59
Multiexponential, multicompartmental, and noncompartmental modeling. II. Data analysis and statistical considerations. Am J Physiol (1984) 2.48
Brain metabolism: a perspective from the blood-brain barrier. Physiol Rev (1983) 2.46
Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J Neurochem (1990) 2.45
Retained asymptomatic third molars and risk for second molar pathology. J Dent Res (2013) 2.43
Enzymic parameters: measurement of V and Km. Biochim Biophys Acta (1971) 2.42
Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. J Immunol (1989) 2.42
Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J (1988) 2.40
Abietadiene synthase from grand fir (Abies grandis): characterization and mechanism of action of the "pseudomature" recombinant enzyme. Biochemistry (2000) 2.31
Lumbar spinal stenosis and nerve root entrapment syndromes. Definition and classification. Clin Orthop Relat Res (1976) 2.25
Cataract in leprosy patients: cataract surgical coverage, barriers to acceptance of surgery, and outcome of surgery in a population based survey in Korea. Br J Ophthalmol (2001) 2.22
Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity (1999) 2.21
Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli. VII. Mapping the ribosomal RNA genes of plasmid F14. J Mol Biol (1974) 2.18
Design and production of novel tetravalent bispecific antibodies. Nat Biotechnol (1997) 2.13
Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli. IV. The F sequences in F14. J Mol Biol (1974) 2.11
Retracted New findings of the correlation between acupoints and corresponding brain cortices using functional MRI. Proc Natl Acad Sci U S A (1998) 2.05
Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. J Biol Chem (1990) 2.04
Natural history of unstable angina. Lancet (1972) 2.03
Three-dimensional evaluation of upper airway in patients with different anteroposterior skeletal patterns. Orthod Craniofac Res (2013) 1.97
Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci U S A (1999) 1.93
Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci U S A (1996) 1.91
A quantitative difference in the immune response between male and female mice. Proc Soc Exp Biol Med (1968) 1.90
The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region. J Exp Med (1991) 1.88
Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. Biochemistry (1995) 1.87
Polypeptide products of nonsense mutations. I. Termination fragments from nonsense mutations in the Z gene of the lac operon of Escherichia coli. J Mol Biol (1970) 1.84
Androgen receptor: an overview. Crit Rev Eukaryot Gene Expr (1995) 1.81
Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol (2000) 1.77
Identification of a new transcriptional initiation site and the corresponding functional gene 2b in the murine coronavirus RNA genome. J Virol (1989) 1.77
Amygdala is critical for stress-induced modulation of hippocampal long-term potentiation and learning. J Neurosci (2001) 1.75
Creation and diagnosis of a solid-density plasma with an X-ray free-electron laser. Nature (2012) 1.74
Novel vectors for the expression of antibody molecules using variable regions generated by polymerase chain reaction. J Immunol Methods (1992) 1.74
Spread of the Spanish multi-resistant serotype 23F clone of Streptococcus pneumoniae to Seoul, Korea. Microb Drug Resist (1997) 1.74
Heavy chain-producing variants of a mouse myeloma cell line. J Immunol (1975) 1.73
Transport of metabolic substrates through the blood-brain barrier. J Neurochem (1977) 1.73
Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation. J Exp Med (1993) 1.73
Absolute pulse energy measurements of soft x-rays at the Linac Coherent Light Source. Opt Express (2014) 1.73
Potential differentiation of human mesenchymal stem cell transplanted in rat corpus cavernosum toward endothelial or smooth muscle cells. Int J Impot Res (2007) 1.72
High prevalence of Gymnophalloides seoi infection in a village on a southwestern island of the Republic of Korea. Am J Trop Med Hyg (1994) 1.68
Factors influencing visualization of vertebral metastases on MR imaging versus bone scintigraphy. AJR Am J Roentgenol (2001) 1.68
Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli. V. ilv+ Deletion mutants of F14. J Mol Biol (1974) 1.68
Folate intake and the risk of colorectal cancer in a Korean population. Eur J Clin Nutr (2009) 1.65
Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse. J Pharmacol Exp Ther (2000) 1.63
Nephropathy of secondary syphilis. A clinical and pathological spectrum. JAMA (1971) 1.63
Thyroid function in nonthyroidal illnesses. Ann Intern Med (1983) 1.62
Delivery of peptides and proteins through the blood-brain barrier. Adv Drug Deliv Rev (2001) 1.62
Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli. IX. Note on the deletion mutant of F, F delta(33-43). J Mol Biol (1974) 1.60
Prognosis of new and worsening angina pectoris. Br Med J (1976) 1.59
Lower respiratory tract infections due to adenovirus in hospitalized Korean children: epidemiology, clinical features, and prognosis. Clin Infect Dis (2001) 1.58
Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion (2000) 1.58
Immunohistochemical study of cerebral amyloid angiopathy. III. Widespread Alzheimer A4 peptide in cerebral microvessel walls colocalizes with gamma trace in patients with leukoencephalopathy. Ann Neurol (1990) 1.57
p53 homologue, p51/p63, maintains the immaturity of keratinocyte stem cells by inhibiting Notch1 activity. Oncogene (2007) 1.56
Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli. VIII. The structure of bacteriophage phi 80d-3ilv+su+7, including the mapping of the ribosomal RNA genes. J Mol Biol (1974) 1.54
Actinomycete infections in humans--a review. Gene (1992) 1.53
Mediated efflux of IgG molecules from brain to blood across the blood-brain barrier. J Neuroimmunol (2001) 1.52
Mortality after vertebral fracture in Korea: analysis of the National Claim Registry. Osteoporos Int (2011) 1.51
Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer. Br J Cancer (2013) 1.50
Murine heavy chain disease. Eur J Immunol (1978) 1.50
Human blood-brain barrier transferrin receptor. Metabolism (1987) 1.50
Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor. Circulation (2001) 1.48
Human blood-brain barrier insulin receptor. J Neurochem (1985) 1.47
GATA-3 significantly downregulates IFN-gamma production from developing Th1 cells in addition to inducing IL-4 and IL-5 levels. Clin Immunol (1999) 1.46
Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis (2001) 1.46
Glucose transport and phosphorylation: which is rate limiting for brain glucose utilization? Ann Neurol (1994) 1.46
Sequence and structure of the catalytic RNA of hepatitis delta virus genomic RNA. J Mol Biol (1992) 1.44
Correlation between sex hormones and magnetic resonance imaging lesions in multiple sclerosis. Acta Neurol Scand (1999) 1.44
Analysis of initial and follow-up CT findings in patients with invasive pulmonary aspergillosis after solid organ transplantation. Clin Radiol (2012) 1.44
Expression pattern of germ cell-specific genes in the testis of patients with nonobstructive azoospermia: usefulness as a molecular marker to predict the presence of testicular sperm. Fertil Steril (2000) 1.44
Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. J Clin Invest (1997) 1.43
Abdominal actinomycosis: CT findings in 10 patients. AJR Am J Roentgenol (1993) 1.43
Peritoneal inclusion cysts and their relationship to the ovaries: evaluation with sonography. Radiology (1997) 1.43
Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport. J Biol Chem (1987) 1.42
Noninvasive gene targeting to the brain. Proc Natl Acad Sci U S A (2000) 1.42
Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. J Clin Invest (1979) 1.42
Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Res (1987) 1.42
A case of Dowling-Degos disease suggesting an evolutional sequence. J Dermatol (2000) 1.42
The origins of cholinergic and other subcortical afferents to the thalamus in the rat. J Comp Neurol (1987) 1.41
Hepatic hemangiomas with arterioportal shunt: findings at two-phase CT. Radiology (2001) 1.41
Minimum 10-year outcome of decompressive laminectomy for degenerative lumbar spinal stenosis. Spine (Phila Pa 1976) (2000) 1.41
A comparison of apparent mRNA half-life using kinetic labeling techniques vs decay following administration of transcriptional inhibitors. Anal Biochem (1991) 1.40
Bioavailable testosterone in salivary glands. Clin Chem (1991) 1.39
Arrangement of the systemic and pulmonary venous components of the atrial chambers in hearts with isomeric atrial appendages. Cardiol Young (2000) 1.39
Characteristic radiographic features of the central ray in Apert syndrome. J Hand Surg Eur Vol (2012) 1.39
Bee venom injection into an acupuncture point reduces arthritis associated edema and nociceptive responses. Pain (2001) 1.39
Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein. Proc Natl Acad Sci U S A (1989) 1.39
Estimation of antibodies specific for dextran. J Immunol (1978) 1.38
Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli. VI. Mapping of F14 sequences homologous to phi 80dmetBJF and phi 80dargECBH bacteriophages. J Mol Biol (1974) 1.38
Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels. J Clin Invest (1997) 1.37
Receptor-mediated peptide transport through the blood-brain barrier. Endocr Rev (1986) 1.35
Production and properties of chimeric antibody molecules. Methods Enzymol (1989) 1.35